期刊文献+

脑脊液细胞因子在帕金森病和非典型帕金森综合征鉴别诊断中的价值

The evaluation of cerebrospinal fluid cytokines in the differential diagnosis of Parkinson disease and atypical parkinsonism
下载PDF
导出
摘要 目的测定帕金森病(Parkinson disease,PD)、多系统萎缩(multiple system atrophy,MSA)、进行性核上性麻痹(progressive supranuclear palsy,PSP)患者与对照组脑脊液(cerebrospinal fluid,CSF)细胞因子水平,并探讨其在疾病鉴别诊断中的价值。方法采用酶联免疫吸附法测定34例PD、18例MSA、23例PSP患者和29例对照组CSF中C-反应蛋白(C-reactive protein,CRP)、白介素(interleukin,IL)-1β(IL-1β)、IL-4、IL-6、IL-10、IL-18、肿瘤坏死因子(tumor necrosis factor,TNF)-α、干扰素(interferon,IFN)-γ和转化生长因子(transforming growth factor,TGF)-β浓度,并使用受试者工作特征曲线分析诊断价值。结果与PD组相比,PSP组CSF中CRP(8766.96±4250.87 vs.5104.33±3843.32 pg/mL)、IL-1β(4.48±2.19 vs.2.35±1.64 pg/mL),TNF-α(124.05±61.90 vs.73.26±45.74 pg/mL),IL-6(84.28±51.29 vs.45.50±37.89 pg/mL)和IL-4(4.60±2.42 vs.2.22±1.43 pg/mL)的浓度增加(P<0.05)。拟合IFN-γ和IL-4生成联合预测因子Pre 1可达PD和PSP最佳诊断效能[曲线下面积(area under curve,AUC)为0.881],Pre 1大于截断值提示PD可能。拟合IFN-γ、IL-1β和TGF-β生成联合预测因子Pre 2可达PD和MSA最佳诊断效能(AUC为0.956),Pre 2大于截断值提示PD可能。结论CSF的IFN-γ和IL-4构建的Pre 1因子升高有助于临床诊断PD而非PSP,IFN-γ、IL-1β和TGF-β构建的Pre 2因子升高对诊断PD而非MSA有一定临床价值。 Objective To quantify the levels of cytokines in the cerebrospinal fluid(CSF)of patients with Parkinson's disease(PD),Multiple system atrophy(MSA)and Progressive supranuclear palsy(PSP)and healthy controls,and investigate the value of CSF cytokines in the differential diagnosis of PD,MSA and PSP.Methods The CSF C-reactive protein(CRP),Interleukin(IL)-1β,IL-4,IL-6,IL-10,IL-18,Tumor Necrosis Factor(TNF)-α,Interferon(IFN)-γand Transforming growth factor(TGF)-βlevels in 34 PD patients,18 MSA patients,23 PSP patients and 29 healthy controls were measured using enzyme-linked immunosorbent assay.The receiver operating characteristic curve was used to analyze the diagnostic value of these cytokines.Results The CSF CRP(8766.96±4250.87 vs.5104.33±3843.32 pg/mL),IL-1β(4.48±2.19 vs.2.35±1.64 pg/mL),TNF-α(124.05±61.90 vs.73.26±45.74 pg/mL),IL-6(84.28±51.29 vs.45.50±37.89 pg/mL)and IL-4(4.60±2.42 vs.2.22±1.43 pg/mL)levels of PSP group were higher than those in PD group(P<0.05).The best diagnostic discrimination(area under curve(AUC)=0.88)between PD and PSP patients was obtained by fitting a combined predictor Pre1 from a subset of cytokines(IFN-γand IL-4),and patients whose Pre1 greater than cut-off value are considered PD.The combined predictor Pre2 from subset of cytokines(IFN-γ,IL-1βand TGF-β)could reach the best diagnostic discrimination between PD and MSA patients(AUC=0.96),and patients whose Pre2 greater than cut-off value are considered PD.Conclusions The elevated Pre1(from CSF IFN-γand IL-4)leads to a clinical diagnosis of PD but not PSP,and elevated Pre2(from CSF IFN-γ,IL-1βand TGF-β)has certain clinical value in diagnosing PD but not MSA.
作者 夏丹豪 项志 付雨 郑倩艺 王玖琦 滕军放 XIA Danhao;XIANG Zhi;FU Yu;ZHENG Qianyi;WANG Jiuqi;TENG Junfang(Department of Neurology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2021年第6期355-360,共6页 Chinese Journal of Nervous and Mental Diseases
基金 国家自然科学基金面上项目(编号:81873719)。
关键词 帕金森病 多系统萎缩 进行性核上性麻痹 脑脊液 细胞因子 Parkinson disease Multiple system atrophy Progressive supranuclear palsy Cerebrospinal fluid Cytokine
  • 相关文献

参考文献3

二级参考文献32

  • 1王含,崔丽英,杜华,李本红.多系统萎缩患者52例的自主神经功能障碍与肛门括约肌肌电图的关系[J].中华神经科杂志,2006,39(2):109-112. 被引量:35
  • 2Wüllner U,Schmitz Hübsch T,Abele M,et al.Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease[J].J Neural Transm,2007,114(9):1161-1165.
  • 3Yabe I,Soma H,Takei A,et al.MSA C is the predominant clinical phenotype of MSA in Japan:analysis of 142 patients with probable MSA[J].J Neurol Sci,2006,249(2):115-121.
  • 4Kao AW,Racine CA,Quitania LC,et al.Cognitive and neuropsychiatric profile of the synucleinopathies:Parkinson disease,dementia with lewy bodies,and multiple system atrophy[J].Alzheimer Dis Assoc Disord,2009,23(4):365-370.
  • 5Chang CC,Chang YY,Chang WN,et al.Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration[J].Eur J Neurol,2009,16(10):1144-1150.
  • 6Gilman S,Wenning GK,Low PA,et al.Second consensus statement on the diagnosis of multiple system atrophy[J].Neurology,2008,71(9):670-676.
  • 7Chang MH,Hung WL,Liao YC,et al.Eye of the tiger-like MRI in parkinsonian variant of multiple system atrope[J].J Neural Transm,2009,116(7):861-866.
  • 8Hauser TK,Luft A,Skalej M,et al.Visualization and quantification of disease progression in multiple system atrophy[J].Mov Disord,2006,21(10):1674-1681.
  • 9Eckert T,Tang C,Ma Y,et al.Abnormal metabolic networks in atypical parkinsonism[J].Mov Disord,2008,23(5):727-733.
  • 10Benarroch EE,Schmeichel AM,Dugger BN,et al.Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia[J].Neurology,2009,73(2):106-112.

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部